Vienna, Austria - A new meta-analysis of 338191 patients enrolled in 50 randomized controlled trials suggests that doses of aspirin over 100 mg have a relatively high risk of hemorrhagic events, ...

Please provide your email address to receive an email when new articles are posted on . ANAHEIM, Calif. — Among patients with stable atherosclerotic vascular disease, a regimen of rivaroxaban 2.5 mg ...

LOS ANGELES, CA—Low-dose rivaroxaban plus low-dose aspirin may have a role for primary or secondary prevention of stroke in patients with stable atherosclerotic vascular disease, according to a ...

According to new data from the COMPASS trial, patients with systemic atherosclerosis assigned low-dose rivaroxaban plus aspirin had reduced risk for cardioembolic stroke and embolic stroke of ...

Guidelines based on study showing BRILINTA reduces risk of cardiovascular events over clopidogrel in patients with Acute Coronary Syndrome WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) ...

Rivaroxaban plus aspirin has significant benefits for patients with peripheral artery disease (PAD) and stable coronary artery disease, according to the results of the COMPASS (Cardiovascular OutcoMes ...

Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin,” researchers ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Use of daily low ...

WASHINGTON, DC (UPDATED)—The combination of low-dose rivaroxaban and P2Y12 inhibition carries a bleeding risk similar to that seen with standard dual antiplatelet therapy after ACS, the phase II ...

Taking low dose aspirin does not protect older women against cognitive decline, finds a large study published on bmj.com today. Identifying ways to prevent dementia is a public health priority.